Background/Objectives: To determine which component of the metabolic syndrome (MetS) is the best predictor of its development. Subjects/Methods: In this cohort study, 2279 subjects aged 20-87 years without MetS selected from among the participants of the cross-sectional phase of the Tehran Lipid and Glucose Study (TLGS) were followed up for development of MetS. Results: After a mean interval of 6.5 years, 462 and 602 new cases of MetS were diagnosed on the basis of the modified Adult Treatment Panel III (ATP III) and International Diabetes Federation (IDF) criteria, respectively. The adjusted odds ratio for development of MetS by ATP III criteria was highest for central obesity in men, 2.8 (2.2-3.7), and for triglycerides (TGs) in women, 2.8 (2.0-4.1). The adjusted odds ratio for the development of MetS by IDF criteria was highest for TGs in both men and women: odds ratio 2.8 (2.2-3.7) and 2.9 (1.9-4.3), respectively. A model that included waist circumference (WC) and TGs or WC and high-density lipoprotein (HDL) predicted MetS similar to a model that included all five MetS components. Conclusion: Screening for the timely prediction of the development of MetS should include measurement of WC, TGs and plasma HDL.
Introduction
The metabolic syndrome (MetS) comprises a set of metabolic risk factors including abdominal obesity, hypertension, dyslipidemia and increased fasting blood glucose levels (Grundy et al., 2005) . A diagnosis of MetS increases the relative risk of a subsequent cardiovascular disease event by 65% and increases the risk of developing type-2 diabetes mellitus by threefold (Ford, 2005; Gami et al., 2007) . According to the Tehran Lipid and Glucose Study (TLGS), the prevalence of MetS (95% confidence interval) is 32.1% (31.2-33.0) based on the International Diabetes Federation (IDF) definition, 33.2% (32.3-34.1) by the Adult Treatment Panel III (ATP III) criteria and 18. 4% (17.6-19 .2) by World Health Organization (WHO) definition (Zabetian et al., 2007) .
Currently, diagnosis is based on specific definition criteria, which vary according to the issuing organization, a fact that produces comparability problems between studies (Alberti and Zimmet, 1998; Balkau and Charles, 1999 ; Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults, 2001; Bloomgarden, 2003; Alberti et al., 2005) . The clinical relevance of MetS as a useful clinical tool is that it identifies people who are at increased longterm risk of cardiovascular disease and type-2 diabetes, thus providing an opportunity for preventive lifestyle interventions or other therapeutic options. Controversies still exist as to the etiology, natural history and treatment of MetS. Data on the natural history and predictors of MetS would be valuable for identifying subjects predisposed to developing the syndrome and would provide valuable insights for implementation of better-designed strategies of community prevention, screening programs and effective interventions.
Considering the high prevalence of MetS (Zabetian et al., 2007) , cardiovascular disease (Hatmi et al., 2007) and diabetes (Esteghamati et al., 2008) in Iranian populations, the objective of this study was to compare the efficacy of various components of MetS in predicting its incidence.
Materials and methods

Subjects
This study was conducted within the framework of the TLGS, a population-based study, conducted on a representative sample of residents of district-13 of Tehran, with the aim of determining the prevalence of noncommunicable disease risk factors and developing a healthy lifestyle to improve these risk factors. The study is divided into two phases: A cross-sectional study of the prevalence of cardiovascular disease and its associated risk factors, and a prospective 20-year follow-up study (Azizi et al., 2000) . In the TLGS, of 15 005 individuals, aged 3 years and above, living in district-13 of Tehran, selected by multistage cluster random sampling methods, 10 368 subjects (4397 men and 5971 women), aged X20 years, were evaluated in the crosssectional phase 1 of TLGS from 1999 to 2001; excluded were those with a history of significant hepatic, renal or thyroid dysfunction, acute or chronic inflammatory diseases, recent surgical operations, myocardial infarction, or a cerebrovascular accident within the previous 3 months, corticosteroid medication, pregnancy and those with MetS (according to ATP III and IDF criteria separately). We also excluded one-third of the study population, as interventions for lifestyle changes were implemented in phases 1 and 2; hence, 2184 and 2237 individuals with MetS by ATP III and IDF criteria, respectively, were not included. Thus, eventually, 3726 subjects without MetS according to ATP III criteria and 3749 subjects without MetS according to IDF criteria with full relevant data at baseline were included in this study (Figure 1) .
Overall, 2460 individuals according to ATP III criteria and 2464 individuals according to IDF criteria completed a 6.5-year follow-up until September 2008. Among nonresponders, the main reasons for lack of participation in the follow-up study were either migration or lack of personal interest. The proposal of this study was approved by the research council of the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences; informed written consent was obtained from all subjects.
Methods
Subjects were interviewed privately, face to face by trained interviewers using pre-tested questionnaires. Initially, information on age, family history of diabetes and medication use was collected. Physical activity level was assessed using a Lipid Research Clinic (LRC) questionnaire (Anisworth et al., 1993) in the first phase of the TLGS. Severe physical activity was defined as exercise or physical activity at least three times a week. Moderate physical activity was defined as exercise or physical activity less than three times a week, and inactive individuals were those with no exercise or physical activity in the past week.
Weight was measured while subjects were minimally clothed without shoes, using digital scales and recorded to the nearest 100 g. Height was measured with subjects in a standing position without shoes, using a tape meter, while the shoulders were in a normal state. Body mass index was calculated as weight in kilograms divided by height in meters squared. Waist circumference (WC) was measured at the level of the umbilicus using an unstretched tape meter, without any pressure to the body surface, and was recorded to the nearest 0.1 cm. All measurements were taken by the same person. To measure blood pressure, subjects were first asked to rest for 15 min, when a qualified physician took the blood pressure twice in a seated position after one initial measurement for determining the peak inflation level using a standard mercury sphygmomanometer. There was at least a 30-s interval between these two separate measurements; thereafter, the mean of the two measurements was considered to be the participant's blood pressure.
A blood sample was taken after 12-14 h of overnight fasting. All blood analyses were performed at the TLGS research laboratory on the day of blood collection. Samples were analyzed using a selectra 2 auto-analyzer (Vital Scientific, Spankeren, The Netherlands). Fasting blood sugar Predictive power of metabolic syndrome development by its components Z Heidari et al was measured on the day of blood collection by the enzymatic colorimetric method using glucose oxidase. For lipid measurements, total cholesterol and triglyceride (TG) kits (Pars Azmoon, Tehran, Iran) were used. Total cholesterol and TG levels were assayed using enzymatic colorimetric tests with cholesterol esterase and cholesterol oxidase, and glycerol phosphate oxidase, respectively. High-density lipoprotein-cholesterol (HDL-C) was measured after precipitation of apolipoprotein B containing lipoproteins with phosphotungstic acid; lipid standard (C.f.a.s., Boehringer Mannheim, Germany; cat. no. 759350) was used to calibrate the selectra 2 auto-analyzer for each day of laboratory analyses. All samples were analyzed when internal quality control met the acceptable criteria. Inter-and intra-assay coefficients of variation were 2 and 0.5% for total cholesterol and 1.6 and 0.6% for TGs, respectively.
Definition of terms
MetS was defined with the criteria proposed by both the NCEP-ATP III (Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults, 2001 ) and the IDF (Alberti et al., 2005) criteria. Under the NCEP-ATP III criteria, MetS was defined as the presence of three or more of the following risk factors: abdominal obesity (WC X102 cm (men) or X88 cm (women)); TGs X1.7 mmol/l; HDL cholesterol o1.03 mmol/l (men) or o1.29 mmol/l (women); blood pressure X130/85 mm Hg; and fasting plasma glucose X5.6 mmol/l. To meet the MetS criteria for IDF, subjects had to have central obesity (waist circumference X94 cm in men and X80 cm in women for the Middle East population), plus any two of the following factors: TGs X1.7 mmol/l or specific treatment for this lipid abnormality; HDL cholesterol o1.03 mmol/l (men) or o1.29 mmol/l (women) or specific treatment for this lipid abnormality; blood pressure X130/85 mm Hg or treatment of previously diagnosed hypertension, and fasting plasma glucose X5.6 mmol/l. The baseline characteristics of the study subjects according to their MetS status at follow-up are shown in Table 1 . Subjects with MetS were older, more obese and on an average had higher WC, blood pressure, blood glucose, plasma TGs and lower HDL-cholesterol, but no significant differences were found in smoking or physical activity status. There were no differences between the participating and nonparticipating groups at follow-up regarding their baseline variables (data are not shown). Table 2 shows the prevalence of the different components of MetS at baseline according to the criteria for each definition's criteria. Low HDL was the most common metabolic abnormality (59.4 and 59.9% according to ATP III and IDF criteria, respectively) and abnormal serum glucose (7.4 and 10.7% according to ATP III and IDF criteria, respectively) was the least common component.
Statistical analyses
Association of the development of MetS with its components is shown in Table 3 . After adjustment for age, smoking and physical activity, according to ATP III criteria, central obesity, hypertriglyceridemia and low HDL predicted its incidence, with central obesity in men and hypertriglyceridemia in women having the greatest magnitude of association. All components individually predicted the development of MetS according to IDF criteria; the adjusted odds ratio for the development of MetS was highest for hypertriglyceridemia in both sexes.
The results of multivariate analysis of factors predicting the development of MetS are shown in Table 4 . Overall, as expected, age, WC, systolic and diastolic blood pressure, fasting plasma glucose, TGs and HDL were independent predictors of MetS by ATPIII and IDF criteria.
The sensitivity, specificity, positive and negative predictive values of the different components of MetS in the prediction of its development according to ATP III and IDF criteria are shown in Table 5 . All the components showed good specificity, and positive and negative predictive values. The sensitivity of predicting MetS was highest for low HDL. The presence of central obesity and hypertriglyceridemia together, as well as central obesity and low HDL, had good specificity and positive and negative predictive value for MetS the basis of either criteria, but sensitivity was low.
The AUCs are shown in Table 6 . According to ATP III criteria, WC in both sexes, and by IDF criteria, WC in men and TGs in women, had the highest AUC. The AUC for fasting plasma glucose was significantly lower than those for other components. The AUCs for all the components in predicting MetS by ATP III criteria were 0.77 (0.74-0.80) in men and 0.82 (0.79-0.84) in women; these values by IDF criteria were 0.77 (0.74-0.80) in men and 0.79 (0.76-0.82) in women. Use of only two components, WC and TGs or WC and HDL, did not result in a significant decline in the AUC. In our study group, WC and TGs together predicted MetS better than single components and were not inferior to using Central obesity: waist circumference X102 cm in men or X88 cm in women according to ATP III criteria and waist circumference X94 cm in men or X80 cm in women according to IDF criteria. High blood pressure: systolic/diastolic blood pressure X130/85 mm Hg or taking blood pressure-lowering medication. Hyperglycemia: fasting plasma glucose X(100 mg per 100 ml). Hypertriglyceridemia: fasting triglycerides X(150 mg per 100 ml). Low HDL: fasting HDL o40 mg per 100 ml or o50 mg per 100 ml in men and women, respectively. Predictive power of metabolic syndrome development by its components Z Heidari et al Hyperglycemia: fasting plasma glucose X(100 mg per 100 ml). Hypertriglyceridemia: fasting triglycerides X(150 mg per 100 ml). Low HDL: fasting HDL o40 mg per 100 ml or o50 mg per 100 ml in men and women, respectively. Central obesity: waist circumference X102 cm in men or X88 cm in women according to ATP III criteria and waist circumference X94 cm in men or X80 cm in women according to IDF criteria. High blood pressure: systolic/diastolic blood pressure X130/85 mm Hg or taking blood pressure-lowering medication. Hyperglycemia: fasting plasma glucose X(100 mg per 100 ml). Hypertriglyceridemia: fasting triglycerides X(150 mg per 100 ml). Low HDL: fasting HDL o40 mg per 100 ml or o50 mg per 100 ml in men and women, respectively.
all the components. Figure 2 shows receiver operating characteristic curves for all components of MetS compared with a two-component model in predicting its development according to ATP III and IDF criteria in men and women.
Discussion
This prospective study in an Iranian cohort, free of MetS at baseline, shows that all components of MetS could predict Our results are in line with the prospective study on a Chinese population, which showed that WC, plasma HDL and TGs predict the development of MetS better than blood pressure and fasting plasma glucose (Cheung et al., 2008) . In a study of White, Black and Hispanic participants, the best predictors of incident MetS in this population were WC, HDL-C and proinsulin (Palaniappan et al., 2004) . Another prospective study on adults in Taiwan showed that higher TGs and larger WC in men independently predicted future incident MetS (Sheu et al., 2006) .
In recent years, Iran has undergone rapid westernization of nutritional habits, with a large part of the population adopting sedentary lifestyles (Sheikholeslam et al., 2004; Ghassemi et al., 2005) , which may have contributed to the increase in overweight and obesity. Lorenzo showed that central adiposity is the major determinant of MetS in Whites residing in the United States and Spain (Lorenzo et al., 2003) . Our observations indicate that central adiposity, HDL-C and TGs are important in predicting MetS in our study cohort. Our findings are in accordance with a consensus report suggesting that central obesity be most pivotal for diagnosis of MetS.
In general, waist measurement is a practical method for self-assessment of health risks because of its ease of measurement and its simple concept of fat distribution (Pouliot et al., 1994; Janssen et al., 2004; Wang et al., 2005) . Changes in WC are very sensitive to weight changes, and health benefits from waist reduction have been shown in relation to improved metabolic and cardiovascular risk factors (Han et al., 1997) .
Obesity was common in our study, as it was in others; this may be because of the high prevalence of general obesity in Iran and the high rate of high waist-to-hip ratio (Bahrami et al., 2006) .
Low HDL-C was the most common metabolic abnormality in both sexes. A low HDL-C has been reported previously in the TLGS population (Azizi et al., 2002) , which could be attributed to industrialization of the country, modification of lifestyle, unhealthy diet, decreased physical activity, increased prevalence of hypertriglyceridemia, obesity and smoking. We assume that in this population, genetic and environmental factors, the exact nature of which remains undetermined, are responsible for low HDL-C.
In this study, the prevalence of hypertension was 14-19% and high blood pressure was a poor predictor. Hypertension has a multifactorial etiology and some findings indicate that about half of the patients with hypertension can have insulin resistance and hyperinsulinemia (Reaven et al., 1996) . Boyko et al. (1995) observed a significant correlation between blood pressure and fasting insulin, independent of overall adiposity in Japanese-Americans.
In our study, hyperglycemia was a poor predictor. Laaksonen et al. (2002) have shown that excluding impaired fasting glucose from the definition of MetS does not affect its specificity. The overall contribution of impaired fasting glucose to the prevalence of MetS is low because of the low prevalence of impaired fasting glucose (7.4-10.7%). Davis (1999) has suggested that impaired fasting glucose alone underestimates the burden of glucose disorders.
This study had some limitations. First, 30% of the participants of our baseline cohort were excluded from analysis because of loss at follow-up; as this group was similar in their baseline characteristic assessments, this may have had no effect on our results. Second, the cutoff points we used for WC in men and women may not be suitable for predicting MetS in our population; thus, large, populationbased, prospective studies may be required for the determination of appropriate cutoff points in this population. Third, we used self-reporting to measure and quantify physical activity, and as this method is more susceptible to recall bias, these results should be interpreted with caution; it is possible that the absence of an association in our findings between physical activity and incidence of MetS was a result of this limitation.
Nevertheless, our study has its strong points, one of which is the use of a large population sample representative of our country, which endorses the validity of our findings. Furthermore, we used actual measurements of anthropometric parameters, rather than self-reported data. In this study, we compared the predictive ability of all individual components and also a combination of components by using receiver operating characteristic curve analysis and the best predictors of MetS development are shown. This provides clinical implication in our population.
The MetS provides an early, simple and inexpensive warning for patients at risk of cardiovascular disease and diabetes, and emphasizes the need to treat those with multiple abnormalities more aggressively, even though individually these abnormalities may be slight.
In conclusion, this 6.5-year prospective study showed the predictors of incident MetS in a cohort of an Iranian population. WC, plasma HDL and TGs predict the development of MetS better than blood pressure or blood glucose and a model that included WC and TGs or WC and HDL predicted MetS in a manner similar to a model that included all five MetS components. High-risk subjects should undergo periodic screening for the timely prediction of the development of MetS, including measurement of WC, TGs and plasma HDL.
